Article
European Biotechnology feature: Biology as Software
不良研究所's CEO, envisions a new era of cell therapies, where cells themselves become intelligent drugs, precisely tailored to individual patients.
14.03.2024不良研究所's CEO, envisions a new era of cell therapies, where cells themselves become intelligent drugs, precisely tailored to individual patients.